LEADER 04440nam 22006495 450 001 9910300230303321 005 20200630023145.0 010 $a1-4939-2035-9 024 7 $a10.1007/978-1-4939-2035-8 035 $a(CKB)3710000000355104 035 $a(EBL)1965009 035 $a(SSID)ssj0001452175 035 $a(PQKBManifestationID)11859294 035 $a(PQKBTitleCode)TC0001452175 035 $a(PQKBWorkID)11478737 035 $a(PQKB)10605681 035 $a(DE-He213)978-1-4939-2035-8 035 $a(MiAaPQ)EBC1965009 035 $a(PPN)184493625 035 $a(EXLCZ)993710000000355104 100 $a20150204d2015 u| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aDuctal Carcinoma In Situ and Microinvasive/Borderline Breast Cancer /$fedited by Lisa A. Newman, Jessica M. Bensenhaver 205 $a1st ed. 2015. 210 1$aNew York, NY :$cSpringer New York :$cImprint: Springer,$d2015. 215 $a1 online resource (171 p.) 300 $aDescription based upon print version of record. 311 $a1-4939-2034-0 320 $aIncludes bibliographical references at the end of each chapters and index. 327 $aEpidemiology of Ductal Carcinoma In Situ -- Role of Screening Mammography in Early Detection/Outcome from Breast Cancer -- Imaging DCIS: Digital/Film Screening Mammography, Tomosynthesis, MRI, Ultrasonography -- Pathology of Ductal Carcinoma In Situ: Features and Diagnostic Challenges -- Molecular Markers in DCIS -- History of Ductal Carcinoma In Situ Management Based Upon Data from Prospective, Randomized Clinical Trials -- Extent and Role of Margin Control for DCIS Managed by Breast-Conserving Surgery -- Ductal Carcinoma In Situ Treated With Breast Conserving Surgery Alone -- DCIS Managed with BCS: Whole-Breast XRT vs. Partial Breast XRT -- Anti-HER2/neu Therapy in DCIS -- Role of Genetic Profiling and Recurrence Scores in Treatment Planning for DCIS -- DCIS and Sentinel Lymph Node Biopsy -- Role of Postmastectomy Radiation for DCIS -- Monitoring and Surveillance Following DCIS Treatment -- DCIS and Hereditary Susceptibility for Breast Cancer -- Introduction, Evolution and Application of the Van Nuys Prognostic Index in DCIS -- Disparities in DCIS Detection and Outcomes Related to Race/Ethnicity. 330 $aThis volume reviews the evolution of information regarding the epidemiology of DCIS and its modes of detection, as well as treatment options as a function of both clinical trial data and ongoing investigational therapeutic prospects. Several of the challenging and clinically-relevant scenarios of DCIS that appear in daily practice is discussed, including the difficulties of distinguishing ?true? DCIS from borderline patterns of other breast diseases and the therapeutic implications of differentiating these various diagnoses. Particular attention is paid to pathologic evaluation of DCIS, including histologic patterns and the importance of margin evaluation/margin control. The text also explores the data regarding DCIS in medical research in hereditary susceptibility for breast cancer and race/ethnicity-associated disparities in breast cancer. Written by experts in the field, Ductal Carcinoma In Situ and Microinvasive/Borderline Breast Cancer is a comprehensive, state-of-the art review of the field, and serves as a valuable resource for clinicians, surgeons and researchers with an interest in breast cancer. 606 $aSurgery 606 $aCancer$xSurgery 606 $aGynecology 606 $aSurgery$3https://scigraph.springernature.com/ontologies/product-market-codes/H59001 606 $aSurgical Oncology$3https://scigraph.springernature.com/ontologies/product-market-codes/H59150 606 $aGynecology$3https://scigraph.springernature.com/ontologies/product-market-codes/H26006 615 0$aSurgery. 615 0$aCancer$xSurgery. 615 0$aGynecology. 615 14$aSurgery. 615 24$aSurgical Oncology. 615 24$aGynecology. 676 $a610 676 $a616994 676 $a617 676 $a618.1 702 $aNewman$b Lisa A$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aBensenhaver$b Jessica M$4edt$4http://id.loc.gov/vocabulary/relators/edt 906 $aBOOK 912 $a9910300230303321 996 $aDuctal Carcinoma In Situ and Microinvasive$91761786 997 $aUNINA